Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1993
11/09/1993US5260212 Cloned gene encoding for bacteriocin from Pediococcus acidilactici
11/09/1993US5260209 Useful for immunization to produce antibodies; diagnosis of genetic defect which causes muscular dystrophy
11/09/1993US5260207 Engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins
11/09/1993US5260205 Anion exchange medium, elution
11/09/1993US5260202 Fermentation method
11/09/1993US5260201 Methods and products for facile microbial expression of DNA sequences
11/09/1993US5260200 Isolated DNA encoding an insulin receptor substrate
11/09/1993US5260199 Gene expression
11/09/1993US5260198 Without using an induction substance such as tysrosine or isopropyl thiogalactoside
11/09/1993US5260189 Synthetic HIV-like peptides their compositions and uses
11/09/1993US5260058 Bacillus thuringiensis isolates active against hymenopteran pests
11/09/1993US5259971 Purifying fibrinogen from liquid containing contaminant with molecular weight lower than fibrinogen by filtering with filter of molecular weight cut-off such that fibrinogen is retained but not contaminant
11/09/1993US5259951 Passing solution of Factor VIII from human plasma through ion exchange chromatographic column using as equilibrating buffer and eluent high ionic strength saline solution at acid pH; stabilizers
11/09/1993CA2095712A1 Development of a mechanism-based screen to identify androgen receptor agonists and antagonists
11/09/1993CA2095490A1 Human metabotropic glutamate receptor and related dna compounds
11/09/1993CA1324097C Inducible heat shock and amplification system
11/09/1993CA1324095C Recombinant ricin toxin
11/09/1993CA1324094C Hepatitis a virus vaccines
11/08/1993CA2095588A1 Synthetic lipid a glycoconjugate antigens for use in vaccines
11/07/1993CA2095693A1 Synthetic polypeptides of the hepatitis c virus (hcv), which may be used to detect the said virus
11/07/1993CA2095577A1 Purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography
11/03/1993EP0568384A1 Human glutamate receptor proteins and associated DNA compounds
11/03/1993EP0568178A1 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
11/03/1993EP0567645A1 Dna which codes for neurotrophic activity inhibitor and use thereof
11/03/1993EP0567626A1 Amylin agonist peptides and uses therefor
11/03/1993EP0567599A1 Megakaryocyte stimulating factors
11/03/1993EP0567586A1 Use of interleukin-10 in adoptive immunotherapy of cancer.
11/03/1993EP0567585A1 HEPATIC GROWTH FACTOR RECEPTOR IS THE $i(MET) PROTO-ONCOGENE
11/03/1993EP0567578A1 Laminin a chain domain vi polypeptides
11/03/1993EP0567577A1 Nucleotidic sequences coding for the murine adrenergic beta 3 receiver and applications thereof
11/03/1993EP0567575A1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof
11/03/1993EP0567568A1 $i(TRANS)-SPLICING RIBOZYMES
11/03/1993EP0567567A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567512A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine
11/03/1993EP0567508A1 Macroscopically oriented cell adhesion protein for wound treatment
11/03/1993EP0567503A1 Pasteurella haemolytica glycoprotease gene
11/03/1993EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/03/1993EP0567450A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
11/03/1993EP0477198B1 Method for recovering recombinant proteins
11/03/1993EP0374182B1 Biospecific polymers
11/03/1993EP0368864B1 Whey protein fractions
11/03/1993CN1077990A Root knot nematode resistance
11/03/1993CN1077961A Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
11/03/1993CN1077960A Hemoregulatory peptides
11/02/1993US5258545 Amino acid derivative, method for preparing the same and method for preparing human osteocalcin using the same
11/02/1993US5258504 Process for the purification of streptolysin O, intact streptolysin O obtainable by this process
11/02/1993US5258502 Immobilization and purification of fusion proteins using chitin-binding ability
11/02/1993US5258497 Process for purifying annexines
11/02/1993US5258496 Precipitation and extraction of proteins
11/02/1993US5258494 Dimeric protein capable of inducing bone and cartilage formation when implanted, in association with a matrix, in a mammal
11/02/1993US5258368 Polypeptides
11/02/1993US5258324 Megakaryocyte colony stimulating factor and process for its preparation
11/02/1993US5258302 DNA for expression of aprotinin in methylotrophic yeast cells
11/02/1993US5258300 Method of inducing lysine overproduction in plants
11/02/1993US5258294 Plasmid cloning vector with genomic library from DNA and virus isolation and insertion a promoter element
11/02/1993US5258288 DNA sequences and genetic vectors
11/02/1993US5258287 DNA sequences and hybrids
11/02/1993US5258283 Detection and differentiation of coxiella burnetii in biological fluids
11/02/1993CA2094987A1 Human glutamate receptor proteins and associated dna compounds
11/02/1993CA1323851C Expression of human proapolipoprotein a-i
11/02/1993CA1323850C Kluyveromyces as a host strain
10/1993
10/30/1993WO1993022682A1 In vitro test for helicobacter pylori
10/30/1993CA2067603A1 Rapid in vitro test for helicobacter pylori using saliva
10/28/1993WO1993021526A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF β-AMYLOID PRECURSOR PROTEIN
10/28/1993WO1993021337A1 Gustducin materials and methods
10/28/1993WO1993021332A1 Hybrid particles
10/28/1993WO1993021331A2 Polysaccharide binding fusion proteins and conjugates
10/28/1993WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993WO1993021327A1 Immortalized human cell lines containing exogenous cytochrome p450 genes
10/28/1993WO1993021325A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993WO1993021324A1 Recombinant mutants for inducing specific immune responses
10/28/1993WO1993021323A1 Haemophilus somnus immunogenic proteins
10/28/1993WO1993021322A1 A method for controlling and determining plant organ morphogenesis, a homeotic gene, a promoter element therefor, and related uses thereof
10/28/1993WO1993021321A2 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
10/28/1993WO1993021320A1 Oil-body proteins as carriers of high-value peptides in plants
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021316A1 Mammalian melanocyte stimulating hormone receptors and uses
10/28/1993WO1993021315A1 Mammalian adrenocorticotropic hormone receptors and uses
10/28/1993WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993WO1993021313A1 Cloning and characterization of a gene, inducible by cytokines
10/28/1993WO1993021312A1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides
10/28/1993WO1993021309A1 Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics
10/28/1993WO1993021308A1 Mutant cytokines having increased receptor affinity
10/28/1993WO1993021306A1 Genetically engineered attenuated viruses
10/28/1993WO1993021303A2 Enhanced purification and expression of insoluble recombinant proteins
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993WO1993021231A1 Adh water channel altering composition
10/28/1993WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993WO1993021228A1 Method for purifying an aqueous solution of raw albumin
10/28/1993WO1993021226A1 Cartilage matrix protein and methods for use
10/28/1993WO1993021225A1 Synthetic peptide, pulmonary surfactant containing the same, and remedy for respiratory distress syndrome
10/28/1993WO1993021224A1 Ultrapure human epidermal growth factor
10/28/1993WO1993021223A1 Methods and reagents for diagnosis of autoantibodies
10/28/1993WO1993021222A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
10/28/1993WO1993021221A1 Pulmonary surfactant protein fragments
10/28/1993WO1993021220A1 Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
10/28/1993WO1993021219A1 Endothelin antagonists ii
1 ... 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 ... 2916